Alethia Young
Analyst at Cantor Fitzgerald
Ticker Coverage
Sector Coverage
Sample Research
Gilead Sciences Inc. (GILD - $68.16)
Mentions in the News
Big Pharma has tried and failed to cure Alzheimer's more than 200 times. The latest $16 billion flop leaves scientists hunting for a new path forward. (BIIB)
A promising, experimental Alzheimer's disease had a major failure on Thursday, when the drugmakers behind it announced they were cutting off most research efforts. Biogen lost roughly $16 billion of market value on the news. Watch Biogen trade in real time. A…
Published: Mar 21 2019
Spectrum’s Neulasta competitor tripped up by manufacturing issues
Spectrum Pharmaceuticals sold off its portfolio of approved drugs and downsized this year so it could concentrate on its development efforts. Now there is a manufacturing hitch affecting the first of its pipeline products up for approval.
Published: Mar 18 2019
Earnings Call Transcripts
MyoKardia (MYOK) CEO Tassos Gianakakos on Q4 2018 Results - Earnings Call Transcript
MyoKardia (NASDAQ:MYOK) Q4 2018 Results Earnings Conference Call March 04, 2019, 08:30 AM ET Company Participants Michelle Corral - Senior Director of Corporate
Published: Mar 4 2019
PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q4 2018 Results - Earnings Call Transcript
PTC Therapeutics (NASDAQ:PTCT) Q4 2018 Earnings Conference Call February 28, 2019 4:30 PM ET Company Participants Emily Hill – Head-Investor Relations Stuart Pe
Published: Mar 1 2019
Would you like to be included in the directory? Let us know!
© Street Contxt. All Rights Reserved.